NEW DELHI — The Central Government has approved a 30% cap on trade margins for non-scheduled cancer medicines, a move expected to make treatment more affordable for patients across India.
According to the Ministry of Chemicals and Fertilizers, the measure could reduce the prices of some medicines by up to 70% and help cancer patients save an estimated ₹2,500 crore every year. The new measure extends price protection to cancer medicines that are not covered by the existing list of drugs with government-set price limits.
An expert committee under the Directorate General of Health Services will finalise the list of medicines covered by the decision. The move aims to reduce the amount patients pay for cancer treatment and improve access to essential medicines.
.png)
The opinions posted here do not belong to 🔰www.indiansdaily.com. The author is solely responsible for the opinions.
As per the IT policy of the Central Government, insults against an individual, community, religion or country, defamatory and inflammatory remarks, obscene and vulgar language are punishable offenses. Legal action will be taken for such expressions of opinion.